Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use (Q41640346)

5 October 2017

1 reference

title

Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use (English)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)03253-4

23 November 2024

1 reference

M. M. Levine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9365466

23 November 2024

O. S. Levine

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9365466

23 November 2024

language of work or name

English

0 references

publication date

1 November 1997

1 reference

5 October 2017

8 November 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9365466

full work available at URL

23 November 2024

https://api.elsevier.com/content/article/PII:S0140673697032534?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)03253-4

https://api.elsevier.com/content/article/PII:S0140673697032534?httpAccept=text/plain

23 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)03253-4

23 November 2024

1 reference

5 October 2017

volume

350

1 reference

5 October 2017

issue

9088

1 reference

5 October 2017

page(s)

1386-1392

1 reference

Pneumococcal disease among children in a rural area of west Africa

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Transmission-blocking vaccines: uses and current status of development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Spread of Vibrio cholerae O139 Bengal in India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Live oral cholera vaccine : from principle to product

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Some observations on poliomyelitis lameness surveys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

A Two-Year Study of Bacterial, Viral, and Parasitic Agents Associated with Diarrhea in Rural Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Incidence and etiology of infantile diarrhea and major routes of transmission in Huascar, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Efficacy trial of malaria vaccine SPf66 in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Safety, Immunogenicity, and Protective Efficacy of One and Three Doses of the Tetravalent Rhesus Rotavirus Vaccine in Infants in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Relation between vaccination and notification rates for whooping cough in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Pertussis in Sweden after the cessation of general immunization in 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

The crisis in vaccine supply: a framework for action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

International childhood vaccine initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

I. Legislative Report: The National Vaccine Injury Compensation Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgR

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Epidemiologic basis for eradication of measles in 1967.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

Vaccine-associated poliomyelitis in the United States, 1961-1972

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903253-4

7 January 2021

The impact of otitis media

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)03253-4

How vaccines are developed

23 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(97)03253-4

23 November 2024

Identifiers

1 reference

5 October 2017

1 reference